COGT Cogent Biosciences
- 9.130
- +0.150+1.67%
- 9.010
- -0.120-1.31%
Cogent Biosciences News
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(9.9%),Point72 Capital Advisors, Inc.(9.9%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(9.3%),Commodore Capital Master LP(9.3%)
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Suvretta Capital Management, LLC(0%),Averill Master Fund, Ltd.(0%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Kynam Capital Management, LP(8.36%),Kynam Capital Management GP, LLC(8.36%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(12.068%),Abigail P. Johnson(12.068%)
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-FMR LLC(7.601%),Abigail P. Johnson(7.601%)
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director CAIN CHRISTOPHER W.
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ros Matthew
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Harwin Peter Evan
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Shegog Todd
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Morris Arlene
Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%)
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Pinnow Cole
Cogent Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Pinnow Cole
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean
Analysis
Price Target
No Data
No Data